Stella Diagnostics (SLDX) Stock Statistics & Valuation Metrics
Total Valuation
Stella Diagnostics has a market cap or net worth of $3.02M. The enterprise value is $13.43T.
- Market Cap
- $3.02M
- Enterprise Value
- $13.43T
Share Statistics
Stella Diagnostics has 301,505,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 301,505,430
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Stella Diagnostics’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 23.95%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- -23.54
- Return on Invested Capital (ROIC)
- 23.95%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 891.91K
- Profits Per Employee
- -2.03M
- Employee Count
- 2
- Asset Turnover
- 10.35
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Stella Diagnostics is -0.71. Stella Diagnostics’s PEG ratio is 0.01.
- PE Ratio
- -0.71
- PS Ratio
- 1.79
- PB Ratio
- -0.10
- Price to FCF
- -1.27
- Price to Operating Cash Flow
- -1.27
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Stella Diagnostics had revenue of 1.78M and earned -4.06M in profits. Earnings per share was -0.01.
- Revenue
- 1.78M
- Gross Profit
- -660.29K
- Operating Income
- -3.45M
- Pretax Income
- -4.06M
- Net Income
- -4.06M
- EBITDA
- -3.45M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -2.37M and capital expenditures 0, giving a free cash flow of -2.37M billion.
- Operating Cash Flow
- -2.37M
- Free Cash Flow
- -2.37M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Stella Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -78.44%
- Earnings Yield
- -144.45%
Stock Price Statistics
- Beta
- -1.46
- 52-Week Price Change
- -33.33%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 4.22
- Average Volume (3m)
- 1,000
Financial Position
Stella Diagnostics as a current ratio of 0.00, with Debt / Equity ratio of -46.44%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 2.33
- Net Debt to EBITDA
- -3.60
- Interest Coverage Ratio
- -5.65
Taxes
In the past 12 months, Stella Diagnostics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Stella Diagnostics EV to EBITDA ratio is -4.17, with an EV/FCF ratio of -7.24.
- EV to Sales
- 10.16
- EV to EBITDA
- -4.17
- EV to Free Cash Flow
- -7.24
- EV to Operating Cash Flow
- -7.24
Balance Sheet
Stella Diagnostics has $7,919.00 in cash and marketable securities with $14.12M in debt, giving a net cash position of -$14.11M billion.
- Cash & Marketable Securities
- $7,919.00
- Total Debt
- $14.12M
- Net Cash
- -$14.11M
- Net Cash Per Share
- -$0.05
- Tangible Book Value Per Share
- -$0.10
Margins
Gross margin is -21.65%, with operating margin of -243.70%, and net profit margin of -258.33%.
- Gross Margin
- -21.65%
- Operating Margin
- -243.70%
- Pretax Margin
- -258.33%
- Net Profit Margin
- -258.33%
- EBITDA Margin
- -243.70%
- EBIT Margin
- -243.70%
Analyst Forecast
The average price target for Stella Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 117.37%
- EPS Growth Forecast
- -135.00%